Maxim Group analyst Michael Okunewitch initiates coverage on Acrivon Therapeutics (NASDAQ:ACRV) with a Buy rating and announces...
Day: October 5, 2023
Caleres Inc (NYSE:CAL) put forward its three-year strategic and financial plan in conjunction with its Oct. 5...
Stryker’s (NYSE:SYK) short percent of float has risen 14.29% since its last report. The company recently reported...
General Mills’s (NYSE:GIS) short percent of float has fallen 6.91% since its last report. The company recently...